Methods comprising apoptosis inhibitors for the generation of transgenic pigs

Stem Cell Clinic
Patient Application
FAQ
Contact
Locations
News
Videos
Research
Patents
3D Culture/Scaffold
Administration
Differentiation
Expansion
Extraction/Preservation
Mobilization
Type
USE
 


Stem Cell Related Patent Number US5821335

Title:Biosynthetic gene murg from streptococcus pneumoniae
Inventors:Hoskins, Jo Ann; Indianapolis, IN, USA
Skatrud, Paul Luther; Indianapolis, IN, USA
Peery, Robert Brown; Brownsburg, IN, USA
Hoskins, Jo Ann; Indianapolis, IN, USA
Skatrud, Paul Luther; Indianapolis, IN, USA
Peery, Robert Brown; Brownsburg, IN, USA
Summary:Described herein is a recombinant Streptococcus pneumoniae MurG protein encoded by nucleic acid and expressed in host cells. The invention relates to isolated nucleic acid compounds encoding the stem peptide biosynthetic gene MurG of Streptococcus pneumoniae. Further provided are vectors and transformed heterologous host cells for expressing the MurG enzyme product, and applications in the identification of compounds that inhibit stem peptide biosynthesis. This invention represents a variation of other applications filed by the same assignee.
Abstract:The invention provides isolated nucleic acid compounds encoding the stem peptide biosynthetic gene murG of Streptococcus pneumoniae. Also provided are vectors and transformed heterologous host cells for expressing the MurG enzyme product and a method for identifying compounds that inhibit stem peptide biosynthesis.
US Patent Website:Click Here for Full Text of Patent
Title Number:US5821335
Application Number:US1996000751474
Date Filed:19/11/1996
Date Published:13/10/1998
Assignee:Eli Lilly and Company, Indianapolis, IN, USA


 
Copyright © 2007 The Institute for Cellular Medicine  8/4/2020